---
figid: PMC7859674__10.1177_0269881120959644-fig3
figlink: pmc/articles/PMC7859674/figure/fig3-0269881120959644/
number: Figure 3
caption: 'Proposed signalling pathways underlying the antidepressant actions of ketamine
  enantiomers and metabolites. Top: (S)-ketamine causes glutamate release via disinhibition
  of γ-aminobutyric acid (GABA) interneurons. Resulting glutamate surge stimulates
  α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors leading to
  release of brain-derived neurotrophic factor (BDNF) with resulting activation of
  tropomyosin kinase B (TrkB)-Akt-mammalian target of rapamycin complex 1 (mTORC1)
  signalling. This leads to increased synthesis of proteins required for synaptogenesis.
  (S)-ketamine and (S)-norketamine suppress resting N-Methyl-D-Aspartate (NMDA) receptor
  activity, deactivating eukaryotic elongation factor 2 (eEF2) kinase, resulting in
  reduced eEF2 phosphorylation, augmentation of BDNF synthesis and TrkB-mTORC1 activation.
  Bottom: (R)-ketamine causes glutamate release via disinhibition of GABA interneurons
  with activation of AMPA receptors and BDNF release but there may be an alternative
  pathway by which (R)-ketamine stimulates AMPA receptor transmission that still needs
  to be elucidated. (R)-ketamine may cause preferential activation of TrkB-MEK-ERK
  signalling pathway leading to synaptogenesis. (2R,6R)-HNK directly activates AMPA
  receptors and inhibition of group II metabotropic glutamate (mGlu2) receptors may
  also be involved in this metabolite’s antidepressant actions.'
pmcid: PMC7859674
papertitle: 'Ketamine: A tale of two enantiomers.'
reftext: Luke A Jelen, et al. J Psychopharmacol. 2021 Feb;35(2):109-123.
pmc_ranked_result_index: '12086'
pathway_score: 0.8203937
filename: 10.1177_0269881120959644-fig3.jpg
figtitle: Proposed signalling pathways underlying the antidepressant actions of ketamine
  enantiomers and metabolites
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7859674__10.1177_0269881120959644-fig3.html
  '@type': Dataset
  description: 'Proposed signalling pathways underlying the antidepressant actions
    of ketamine enantiomers and metabolites. Top: (S)-ketamine causes glutamate release
    via disinhibition of γ-aminobutyric acid (GABA) interneurons. Resulting glutamate
    surge stimulates α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors
    leading to release of brain-derived neurotrophic factor (BDNF) with resulting
    activation of tropomyosin kinase B (TrkB)-Akt-mammalian target of rapamycin complex
    1 (mTORC1) signalling. This leads to increased synthesis of proteins required
    for synaptogenesis. (S)-ketamine and (S)-norketamine suppress resting N-Methyl-D-Aspartate
    (NMDA) receptor activity, deactivating eukaryotic elongation factor 2 (eEF2) kinase,
    resulting in reduced eEF2 phosphorylation, augmentation of BDNF synthesis and
    TrkB-mTORC1 activation. Bottom: (R)-ketamine causes glutamate release via disinhibition
    of GABA interneurons with activation of AMPA receptors and BDNF release but there
    may be an alternative pathway by which (R)-ketamine stimulates AMPA receptor transmission
    that still needs to be elucidated. (R)-ketamine may cause preferential activation
    of TrkB-MEK-ERK signalling pathway leading to synaptogenesis. (2R,6R)-HNK directly
    activates AMPA receptors and inhibition of group II metabotropic glutamate (mGlu2)
    receptors may also be involved in this metabolite’s antidepressant actions.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GRM2
  - EEF2
  - GSK3A
  - GSK3B
  - BDNF
  - MAPK3
  - MAPK1
  - AKT2
  - AKT3
  - AKT1
  - MAP2K1
  - MAP2K2
  - NTRK2
  - NMDA
  - Ketamine
  - Norketamine
  - GABA
  - Glutamate
  - AMPA
  - (S)-Norketamine
genes:
- word: mGlu2
  symbol: mGlu2
  source: hgnc_alias_symbol
  hgnc_symbol: GRM2
  entrez: '2912'
- word: EEF2
  symbol: EEF2
  source: hgnc_symbol
  hgnc_symbol: EEF2
  entrez: '1938'
- word: p-EEF2
  symbol: EEF2
  source: hgnc_symbol
  hgnc_symbol: EEF2
  entrez: '1938'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: TrkB
  symbol: TRKB
  source: hgnc_alias_symbol
  hgnc_symbol: NTRK2
  entrez: '4915'
- word: EEF2
  symbol: EEF2
  source: hgnc_symbol
  hgnc_symbol: EEF2
  entrez: '1938'
- word: p-EEF2
  symbol: EEF2
  source: hgnc_symbol
  hgnc_symbol: EEF2
  entrez: '1938'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: BDNF
  symbol: BDNF
  source: hgnc_symbol
  hgnc_symbol: BDNF
  entrez: '627'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: TrkB
  symbol: TRKB
  source: hgnc_alias_symbol
  hgnc_symbol: NTRK2
  entrez: '4915'
- word: mGlu2
  symbol: mGlu2
  source: hgnc_alias_symbol
  hgnc_symbol: GRM2
  entrez: '2912'
chemicals:
- word: NMDA
  source: ''
  identifier: ''
- word: Ketamine
  source: MESH
  identifier: D007649
- word: Norketamine
  source: MESH
  identifier: C033419
- word: GABA
  source: MESH
  identifier: D005680
- word: Glutamate
  source: ''
  identifier: ''
- word: AMPA
  source: MESH
  identifier: D018350
- word: (S)-Norketamine
  source: MESH
  identifier: C033419
diseases: []
---
